Profound Medical Regains Exclusive Distribution Rights for TULSA-PRO® in Canada from Knight

Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), a commercial-stage medical device company that develops and markets artificial intelligence (“AI”)-powered, MRI-guided, ...

Profound Medical Announces Strategic Distribution Agreement with Getz Healthcare to Bring TULSA-PRO® to Australia and New Zealand

"Our exclusive partnership with Profound Medical marks a significant step in advancing precision prostate care across Australia and New Zealand,” commented Getz Healthcare ANZ Managing Director, Derek ...
Medical Dialogues

Revolutionizing gynecologic pain management: Exploring modern trends and innovations

Modern obstetric advances have improved labor management with pain medication integration, yet gynecologic pain management ...

Profound Medical Corp.: Profound Medical Announces Strategic Distribution Agreement with Getz Healthcare to Bring TULSA-PRO to Australia and New Zealand

Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) ("Profound" or the "Company"), a commercial-stage medical device company that develops and markets AI-powered ...
WSAV-TV on MSN

ONLY ON 3: New robotic technology pushes boundaries for removing lung cancer

Doctors at St. Joseph’s/Candler are able to precisely locate and attack potential cancerous nodules with the help of robotic ...

Gynaecological Devices Market Set to Reach USD 21.11 Billion By 2033, Due to Advances in Surgical and Diagnostic Technologies - SNS Insider

Increasing awareness about women's health and minimally invasive measures are shaping the expansion of the global market.Austin, Nov. 12, 2025 (GLOBE NEWSWIRE) -- Gynaecology Devices Market Size and ...
Cure Today

What’s the Plan for Patients With Melanoma After Surgery?

“When we talk about recurrence of melanoma, we actually worry more about what we cannot see, what's on the inside,” Dr. Justine V. Cohen of the Dana-Farber Cancer Institute told CURE®. Patients with ...